Osteopathic Manipulative Treatment vs Physiotherapy in Cervicocranial Dysfunction (OMT-CCD)

April 21, 2026 updated by: Burim Peli

Comparative Effects of Osteopathic Manipulative Treatment and Standard Physiotherapy on Dizziness, Headache Impact, Neck Disability, and Psychological Stress in Patients With Cervicocranial Dysfunction: A Randomized Controlled Trial

This study aims to compare the effects of osteopathic manipulative treatment and standard physiotherapy in patients with cervicocranial dysfunction. The study will evaluate outcomes including dizziness, headache impact, neck disability, and psychological stress.

Participants will be randomly assigned to one of two groups: osteopathic treatment or standard physiotherapy. The interventions will be applied over a defined treatment period, and outcomes will be measured before and after the intervention.

The purpose of this study is to determine which approach is more effective in improving symptoms and functional outcomes in patients with cervicocranial dysfunction.

Study Overview

Detailed Description

Cervicocranial dysfunction is commonly associated with symptoms such as dizziness, headache, neck pain, and psychological stress, which significantly affect patients' quality of life. Various therapeutic approaches are used in clinical practice, including osteopathic manipulative treatment (OMT) and standard physiotherapy; however, comparative evidence between these approaches remains limited.

This randomized controlled trial aims to evaluate the comparative effectiveness of osteopathic manipulative treatment versus standard physiotherapy in patients diagnosed with cervicocranial dysfunction. Participants will be randomly allocated into two groups. The experimental group will receive osteopathic manipulative treatment, while the control group will receive standard physiotherapy interventions.

Outcome measures will include dizziness intensity, headache impact, neck disability index, and psychological stress levels. Assessments will be conducted at baseline and after completion of the intervention period.

The results of this study are expected to provide evidence regarding the effectiveness of osteopathic treatment compared to conventional physiotherapy and contribute to improving clinical decision-making in the management of cervicocranial dysfunction.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Pejton
      • Pristina, Pejton, Kosovo, 30000
        • Recruiting
        • Imperium Medical Clinic
        • Contact:
          • Burim Peli Peli Burim, MSc physiotherapy, Phd Cand,
          • Phone Number: +38349600053
          • Email: burimpeli@hotmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Participants will be eligible for inclusion in the study if they meet the following criteria:

    • Age between 18 and 65 years.
    • Presence of cervicocranial symptoms for at least three months, indicating a chronic condition.
    • Neck pain with or without associated headache.
    • Dizziness associated with neck movement or cervical position.
    • Clinical findings consistent with cervicocranial dysfunction, based on clinical examination.
    • Ability to understand and complete standardized clinical questionnaires used in the study.
    • Willingness to participate in the study and provision of written informed consent.

Exclusion Criteria:

  • Participants will be excluded from the study if they present with any of the following conditions:

    • Clinically confirmed vestibular disorders.
    • Central neurological disorders that may influence dizziness or balance.
    • Recent severe trauma to the cervical spine.
    • History of cervical spine surgery.
    • Systemic inflammatory diseases or serious spinal pathologies.
    • Presence of red flags related to the cervical spine identified during clinical screening.
    • Participation in concurrent intensive physiotherapy or rehabilitation treatment during the study period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Participants in this group will receive osteopathic manipulative treatment (OMT) targeting cervicocr
OMT
Conventional physiotherapy including therapeutic exercises, manual therapy, and physical modalities such as TENS and heat therapy
Active Comparator: Participants in this group will receive standard physiotherapy treatment including therapeutic exerc
conventional physiotherapy
physiotherapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change in Headache Impact Test (HIT-6) total score
Time Frame: Baseline and Week 4
Mean change in HIT-6 total score from baseline to Week 4. Higher scores indicate greater headache impact.
Baseline and Week 4
Mean change in Dizziness Handicap Inventory (DHI) total score
Time Frame: Baseline and Week 4
The DHI is a 25-item questionnaire assessing dizziness-related disability (score range: 0-100). Mean change from baseline to Week 4 will be calculated.
Baseline and Week 4
Mean change in Neck Disability Index (NDI) total score
Time Frame: Baseline and Week 4
The NDI assesses neck-related disability (score range: 0-50). Mean change from baseline to Week 4 will be calculated.
Baseline and Week 4
Mean change in Perceived Stress Scale (PSS-10) total score
Time Frame: Baseline and Week 4
Mean change in PSS-10 total score from baseline to Week 4. Higher scores indicate greater perceived stress.
Baseline and Week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change in Numeric Rating Scale (NRS) score for neck pain
Time Frame: Baseline and Week 4
Mean change in neck pain intensity measured using the 11-point Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain) from baseline to Week 4.
Baseline and Week 4
Mean change in Numeric Rating Scale (NRS) score for headache intensity
Time Frame: Baseline and Week 4
Mean change in headache intensity measured using the 11-point Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain) from baseline to Week 4.
Baseline and Week 4
Mean change in Tampa Scale of Kinesiophobia (TSK) total score
Time Frame: Baseline and Week 4
Mean change in fear of movement measured using the TSK total score from baseline to Week 4. Higher scores indicate greater kinesiophobia.
Baseline and Week 4
Mean change in Pain Catastrophizing Scale (PCS) total score
Time Frame: Baseline and Week 4
Mean change in pain catastrophizing measured using the PCS total score from baseline to Week 4. Higher scores indicate greater catastrophizing.
Baseline and Week 4
Mean change in cervical range of motion (degrees)
Time Frame: Baseline and Week 4
Mean change in active cervical range of motion (flexion, extension, rotation, lateral flexion) measured in degrees using a goniometer from baseline to Week 4.
Baseline and Week 4
Mean change in Flexion-Rotation Test (FRT) range (degrees)
Time Frame: Baseline and Week 4
Mean change in upper cervical rotation range measured using the Flexion-Rotation Test (FRT) in degrees from baseline to Week 4.
Baseline and Week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

September 30, 2026

Study Registration Dates

First Submitted

April 3, 2026

First Submitted That Met QC Criteria

April 21, 2026

First Posted (Actual)

April 29, 2026

Study Record Updates

Last Update Posted (Actual)

April 29, 2026

Last Update Submitted That Met QC Criteria

April 21, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Individual participant data (IPD) will not be shared due to confidentiality and ethical restrictions related to patient data protection.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dizziness

Clinical Trials on Participants in this group will receive osteopathic manipulative treatment (OMT) targeting cervicocr

Subscribe